Literature DB >> 17888627

Innate and adaptive immune response to apoptotic cells.

Yufeng Peng1, David A Martin, Justin Kenkel, Kang Zhang, Carol Anne Ogden, Keith B Elkon.   

Abstract

The immune system is constantly exposed to dying cells, most of which arise during central tolerance and from effete circulating immune cells. Under homeostatic conditions, phagocytes (predominantly macrophages and dendritic cells) belonging to the innate immune system, rapidly ingest cells and their debris. Apoptotic cell removal requires recognition of altered self on the apoptotic membrane, a process which is facilitated by natural antibodies and serum opsonins. Recognition, may be site and context specific. Uptake and ingestion of apoptotic cells promotes an immunosuppressive environment that avoids inflammatory responses to self-antigens. However, it does not preclude a T cell response and it is likely that constant exposure to self-antigen, particularly by immature dendritic cells, leads to T cell tolerance. Tolerance occurs by several different mechanisms including anergy and deletion (for CD8+T cells) and induction of T regulatory cells (for CD4+T cells). Failed apoptotic cell clearance promotes immune responses to self-antigens, especially when the cellular contents are leaked from the cell (necrosis). Inflammatory responses may be induced by nucleic acid stimulation of Toll like receptors and other immune sensors, specific intracellular proteins and non-protein (uric acid) stimulation of inflammasomes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17888627      PMCID: PMC2100400          DOI: 10.1016/j.jaut.2007.07.017

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  65 in total

1.  Natural adjuvants: endogenous activators of dendritic cells.

Authors:  S Gallucci; M Lolkema; P Matzinger
Journal:  Nat Med       Date:  1999-11       Impact factor: 53.440

2.  Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes.

Authors:  Shalin H Naik; Donald Metcalf; Annemarie van Nieuwenhuijze; Ian Wicks; Li Wu; Meredith O'Keeffe; Ken Shortman
Journal:  Nat Immunol       Date:  2006-05-07       Impact factor: 25.606

3.  A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse.

Authors:  Bronwyn A O'Brien; Xuan Geng; Catherine H Orteu; Yongqian Huang; Mehran Ghoreishi; YiQun Zhang; Jason A Bush; Gang Li; Diane T Finegood; Jan Peter Dutz
Journal:  J Autoimmun       Date:  2006-01-20       Impact factor: 7.094

Review 4.  Homeostatic roles of naturally occurring antibodies: an overview.

Authors:  Hans U Lutz
Journal:  J Autoimmun       Date:  2007-09-12       Impact factor: 7.094

5.  Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages.

Authors:  Kohki Kawane; Mayumi Ohtani; Keiko Miwa; Takuji Kizawa; Yoshiyuki Kanbara; Yoshichika Yoshioka; Hideki Yoshikawa; Shigekazu Nagata
Journal:  Nature       Date:  2006-10-26       Impact factor: 49.962

6.  Human CD14 mediates recognition and phagocytosis of apoptotic cells.

Authors:  A Devitt; O D Moffatt; C Raykundalia; J D Capra; D L Simmons; C D Gregory
Journal:  Nature       Date:  1998-04-02       Impact factor: 49.962

Review 7.  B cell targeted therapy in autoimmunity.

Authors:  Miri Blank; Yehuda Shoenfeld
Journal:  J Autoimmun       Date:  2007-03-27       Impact factor: 7.094

8.  Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production.

Authors:  Adrian E Morelli; Adriana T Larregina; William J Shufesky; Alan F Zahorchak; Alison J Logar; Glenn D Papworth; Zhiliang Wang; Simon C Watkins; Louis D Falo; Angus W Thomson
Journal:  Blood       Date:  2002-09-05       Impact factor: 22.113

9.  The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis-associated neo-antigens and apoptotic cells.

Authors:  Peter X Shaw; Carl S Goodyear; Mi-Kyung Chang; Joseph L Witztum; Gregg J Silverman
Journal:  J Immunol       Date:  2003-06-15       Impact factor: 5.422

Review 10.  Auto-reactive B cells in transgenic mice.

Authors:  Jean-Louis Pasquali; Pauline Soulas-Sprauel; Anne-Sophie Korganow; Thierry Martin
Journal:  J Autoimmun       Date:  2007-09-12       Impact factor: 7.094

View more
  66 in total

1.  Differential effects of viral vectors on migratory afferent lymph dendritic cells in vitro predict enhanced immunogenicity in vivo.

Authors:  C Cubillos-Zapata; E Guzman; A Turner; S C Gilbert; H Prentice; J C Hope; B Charleston
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

Review 2.  Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells.

Authors:  Zhao-Hua Zhou; Athanasios G Tzioufas; Abner Louis Notkins
Journal:  J Autoimmun       Date:  2007-09-20       Impact factor: 7.094

Review 3.  The geo-epidemiology of temporal (giant cell) arteritis.

Authors:  Jennifer L Lee; Stanley M Naguwa; Gurtej S Cheema; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

4.  Vasculitis: current status and future directions.

Authors:  Pierre Youinou
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

5.  Infusion of UVB-treated splenic stromal cells induces suppression of beta cell antigen-specific T cell responses in NOD mice.

Authors:  Chang-Qing Xia; Yushi Qiu; Rui-Hua Peng; Jeannette Lo-Dauer; Michael J Clare-Salzler
Journal:  J Autoimmun       Date:  2008-01-15       Impact factor: 7.094

6.  Cutting edge issues in autoimmunity.

Authors:  Yaniv Sherer; Torsten Matthias; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

7.  Anti-factor VIII antibodies (Inhibitors) in hemophilia A: in dire need of basic and therapeutic research.

Authors:  Srini V Kaveri
Journal:  Clin Rev Allergy Immunol       Date:  2009-10       Impact factor: 8.667

Review 8.  Atherosclerosis and autoimmunity.

Authors:  Eiji Matsuura
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

Review 9.  Animal models of primary biliary cirrhosis.

Authors:  Ya-Hui Chuang; William M Ridgway; Yoshiyuki Ueno; M Eric Gershwin
Journal:  Clin Liver Dis       Date:  2008-05       Impact factor: 6.126

10.  TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus.

Authors:  Kevin M Nickerson; Sean R Christensen; Jonathan Shupe; Michael Kashgarian; Daniel Kim; Keith Elkon; Mark J Shlomchik
Journal:  J Immunol       Date:  2010-01-20       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.